Insider Transactions in Q2 2023 at Gilead Sciences, Inc. (GILD)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2023
|
Merdad Parsey Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,485
-4.81%
|
$112,860
$76.9 P/Share
|
|
Jun 10
2023
|
Sandra Patterson SVP, Controllership |
SELL
Payment of exercise price or tax liability
|
Direct |
153
-0.57%
|
$11,934
$78.12 P/Share
|
|
Jun 10
2023
|
Sandra Patterson SVP, Controllership |
BUY
Exercise of conversion of derivative security
|
Direct |
517
+1.9%
|
-
|
|
Jun 10
2023
|
Merdad Parsey Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,294
-4.02%
|
$100,932
$78.12 P/Share
|
|
Jun 10
2023
|
Merdad Parsey Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,779
+7.95%
|
-
|
|
Jun 10
2023
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,272
-2.81%
|
$99,216
$78.12 P/Share
|
|
Jun 10
2023
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,730
+5.69%
|
-
|
|
Jun 10
2023
|
Daniel Patrick O'Day Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,409
-1.26%
|
$265,902
$78.12 P/Share
|
|
Jun 10
2023
|
Daniel Patrick O'Day Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,346
+2.65%
|
-
|
|
Jun 10
2023
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,219
-1.63%
|
$95,082
$78.12 P/Share
|
|
Jun 10
2023
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,618
+3.38%
|
-
|
|
May 03
2023
|
Jacqueline K Barton Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,887
+7.82%
|
-
|
|
May 03
2023
|
Sandra Horning Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,887
+34.2%
|
-
|
|
May 03
2023
|
Kevin E Lofton Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,887
+2.0%
|
-
|
|
May 03
2023
|
Harish Manwani Director |
SELL
Payment of exercise price or tax liability
|
Direct |
368
-3.23%
|
$29,072
$79.45 P/Share
|
|
May 03
2023
|
Harish Manwani Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,887
+14.22%
|
-
|
|
May 03
2023
|
Javier Rodriguez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,887
+18.36%
|
-
|
|
May 03
2023
|
Anthony Welters Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,887
+19.24%
|
-
|
|
May 01
2023
|
Kevin E Lofton Director |
SELL
Bona fide gift
|
Indirect |
12,868
-12.42%
|
-
|